Search
Now showing items 1-5 of 5
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya
(University of Nairobi, 2004)
Safety Issues, DNA & MVA HIV Vaccine Trials at KAVI Oral presentation
(University of Nairobi, 2003-01)
The Use of Viral Peptides as a Quality Control for ELISPOT Assays in HIV-1 Vaccine Trials in Kenya
(University of Nairobi,, 2004)
Abstract no. A10065"
CD4 and CD8 T - Lymphocyte distribution amoung healthy Kenyans enrolling in an HIV vaccine trial
(University of Nairobi,, 2004)
Abstract no. ThPeA7001"
HIV vaccine clinical trials enrollment and retention: Experience from Kenya AIDS Vaccine Initiative
(University of Nairobi, 2005)